Abbreviated Name

HEDS Ref Set App: Singal (2021) PLSec

Lead Investigator

Singal, Amit — UT Southwestern Medical Center

Coordinating Investigator

Feng, Ziding — Fred Hutchinson Cancer Center

Involved Investigators

• Feng, Ziding — Fred Hutchinson Cancer Center
• Singal, Amit — UT Southwestern Medical Center

Abstact

see objectives

Aims

To validate the performance of a blood-based molecular signature, Prognostic Liver Secretome signature (PLSec), to predict long-term risk of developing HCC in cirrhosis patients.

Analytic Method

Biomarker will be run blinded to clinical outcome

Outcome

Validate predictive biomarker for development of HCC in patients with cirrhosis

Publications

• No publications available at this time for this protocol.

Biomarkers

• No biomarkers available at this time for this protocol.

Data Collections

• No data collections available at this time for this protocol.

 Team Project

Start Date

May 1 2021

Estimated Finish Date

Feb 1 2022

Finish Date

Nov 17 2021

Protocol ID

493

Protocol Type

Reference Set

Field of Research

Proteomics

Collaborative Group

G.I. and Other Associated Cancers Research Group

Cancer Types

• Liver cell carcinoma